Vincent Vinciguerra Selected Research

Cisplatin (Platino)

2/2010

A phase I trial of oblimersen sodium in combination with cisplatin and 5-fluorouracil in patients with advanced esophageal, gastroesophageal junction, and gastric carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincent Vinciguerra Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2011 - 04/2010
2	Neoplasms (Cancer) 12/2006 - 08/2005
1	Fatigue 01/2021
1	Anxiety Disorders (Anxiety Disorder) 01/2021
1	Pain (Aches) 01/2021
1	Disease Progression 04/2010
1	Adenocarcinoma 04/2010
1	Carcinoma (Carcinomatosis) 02/2010
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2010
1	Body Weight (Weight, Body) 12/2006
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2002

Drug/Important Bio-Agent (IBA)

1	Paclitaxel (Taxol)FDA LinkGeneric 04/2010
1	Protein Kinase CIBA 04/2010
1	Fluorouracil (Carac)FDA LinkGeneric 02/2010
1	oblimersen (G3139)IBA 02/2010
1	Antisense OligonucleotidesIBA 02/2010
1	Messenger RNA (mRNA)IBA 02/2010
1	Cisplatin (Platino)FDA LinkGeneric 02/2010
1	Dietary Fats (Dietary Fat)IBA 12/2006
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 08/2005
1	LY 293111 (LY293111)IBA 08/2005
1	Immunoglobulin Variable RegionIBA 09/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 02/2010
1	Mastectomy (Mammectomy) 01/2021
1	Radiotherapy 01/2021
1	Neoadjuvant Therapy 02/2011
1	Therapeutics 04/2010